47 related articles for article (PubMed ID: 15601621)
1. Interleukin-6 increases rat metalloproteinase-13 gene expression through Janus kinase-2-mediated inhibition of serine/threonine phosphatase-2A.
de la Torre P; Díaz-Sanjuán T; García-Ruiz I; Esteban E; Canga F; Muñoz-Yagüe T; Solís-Herruzo JA
Cell Signal; 2005 Apr; 17(4):427-35. PubMed ID: 15601621
[TBL] [Abstract][Full Text] [Related]
2. Role of janus kinase-2 in insulin-mediated phosphorylation and inactivation of protein phosphatase-2A and its impact on upstream insulin signalling components.
Begum N; Ragolia L
Biochem J; 1999 Dec; 344 Pt 3(Pt 3):895-901. PubMed ID: 10585879
[TBL] [Abstract][Full Text] [Related]
3. Involvement of protein phosphatase 2A in the interleukin-3-stimulated Jak2-Stat5 signaling pathway.
Yokoyama N; Reich NC; Miller WT
J Interferon Cytokine Res; 2001 Jun; 21(6):369-78. PubMed ID: 11440634
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-6 increases rat metalloproteinase-13 gene expression through stimulation of activator protein 1 transcription factor in cultured fibroblasts.
Solís-Herruzo JA; Rippe RA; Schrum LW; de La Torre P; García I; Jeffrey JJ; Muñoz-Yagüe T; Brenner DA
J Biol Chem; 1999 Oct; 274(43):30919-26. PubMed ID: 10521486
[TBL] [Abstract][Full Text] [Related]
5. Phenyl N-tert-butylnitrone down-regulates interleukin-1 beta-stimulated matrix metalloproteinase-13 gene expression in human chondrocytes: suppression of c-Jun NH2-terminal kinase, p38-mitogen-activated protein kinase and activating protein-1.
Ahmed S; Rahman A; Hasnain A; Goldberg VM; Haqqi TM
J Pharmacol Exp Ther; 2003 Jun; 305(3):981-8. PubMed ID: 12626640
[TBL] [Abstract][Full Text] [Related]
6. Transcriptional induction of cyclooxygenase-2 gene by okadaic acid inhibition of phosphatase activity in human chondrocytes: co-stimulation of AP-1 and CRE nuclear binding proteins.
Miller C; Zhang M; He Y; Zhao J; Pelletier JP; Martel-Pelletier J; Di Battista JA
J Cell Biochem; 1998 Jun; 69(4):392-413. PubMed ID: 9620167
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-1 induction of collagenase 3 (matrix metalloproteinase 13) gene expression in chondrocytes requires p38, c-Jun N-terminal kinase, and nuclear factor kappaB: differential regulation of collagenase 1 and collagenase 3.
Mengshol JA; Vincenti MP; Coon CI; Barchowsky A; Brinckerhoff CE
Arthritis Rheum; 2000 Apr; 43(4):801-11. PubMed ID: 10765924
[TBL] [Abstract][Full Text] [Related]
8. IL-1 and TNF induction of matrix metalloproteinase-3 by c-Jun N-terminal kinase in trabecular meshwork.
Hosseini M; Rose AY; Song K; Bohan C; Alexander JP; Kelley MJ; Acott TS
Invest Ophthalmol Vis Sci; 2006 Apr; 47(4):1469-76. PubMed ID: 16565381
[TBL] [Abstract][Full Text] [Related]
9. IL-1beta induces MMP-9 expression via a Ca2+-dependent CaMKII/JNK/c-JUN cascade in rat brain astrocytes.
Wu CY; Hsieh HL; Sun CC; Yang CM
Glia; 2009 Dec; 57(16):1775-89. PubMed ID: 19455716
[TBL] [Abstract][Full Text] [Related]
10. Regulation and function of protein kinase B and MAP kinase activation by the IL-5/GM-CSF/IL-3 receptor.
Dijkers PF; van Dijk TB; de Groot RP; Raaijmakers JA; Lammers JW; Koenderman L; Coffer PJ
Oncogene; 1999 Jun; 18(22):3334-42. PubMed ID: 10362354
[TBL] [Abstract][Full Text] [Related]
11. Apoptosis induced by protein phosphatase 2A (PP2A) inhibition in T leukemia cells is negatively regulated by PP2A-associated p38 mitogen-activated protein kinase.
Boudreau RT; Conrad DM; Hoskin DW
Cell Signal; 2007 Jan; 19(1):139-51. PubMed ID: 16844342
[TBL] [Abstract][Full Text] [Related]
12. Activation of fibroblast collagenase-1 expression by tumor cells of squamous cell carcinomas is mediated by p38 mitogen-activated protein kinase and c-Jun NH2-terminal kinase-2.
Westermarck J; Li S; Jaakkola P; Kallunki T; Grénman R; Kähäri VM
Cancer Res; 2000 Dec; 60(24):7156-62. PubMed ID: 11156425
[TBL] [Abstract][Full Text] [Related]
13. Extracellular-regulated kinase 1/2, Jun N-terminal kinase, and c-Jun are involved in NF-kappa B-dependent IL-6 expression in human monocytes.
Tuyt LM; Dokter WH; Birkenkamp K; Koopmans SB; Lummen C; Kruijer W; Vellenga E
J Immunol; 1999 Apr; 162(8):4893-902. PubMed ID: 10202034
[TBL] [Abstract][Full Text] [Related]
14. Tyrosine phosphorylation of Vav stimulates IL-6 production in mast cells by a Rac/c-Jun N-terminal kinase-dependent pathway.
Song JS; Haleem-Smith H; Arudchandran R; Gomez J; Scott PM; Mill JF; Tan TH; Rivera J
J Immunol; 1999 Jul; 163(2):802-10. PubMed ID: 10395673
[TBL] [Abstract][Full Text] [Related]
15. Janus kinase-signal transducer and activator of transcription mediates phosphatidic acid-induced interleukin (IL)-1beta and IL-6 production.
Lee C; Lim HK; Sakong J; Lee YS; Kim JR; Baek SH
Mol Pharmacol; 2006 Mar; 69(3):1041-7. PubMed ID: 16354768
[TBL] [Abstract][Full Text] [Related]
16. Hydrogen peroxide-induced neuronal apoptosis is associated with inhibition of protein phosphatase 2A and 5, leading to activation of MAPK pathway.
Chen L; Liu L; Yin J; Luo Y; Huang S
Int J Biochem Cell Biol; 2009 Jun; 41(6):1284-95. PubMed ID: 19038359
[TBL] [Abstract][Full Text] [Related]
17. Expression of I2PP2A, an inhibitor of protein phosphatase 2A, induces c-Jun and AP-1 activity.
Al-Murrani SW; Woodgett JR; Damuni Z
Biochem J; 1999 Jul; 341 ( Pt 2)(Pt 2):293-8. PubMed ID: 10393085
[TBL] [Abstract][Full Text] [Related]
18. Caffeine induces matrix metalloproteinase-2 (MMP-2) and MMP-9 down-regulation in human leukemia U937 cells via Ca2+/ROS-mediated suppression of ERK/c-fos pathway and activation of p38 MAPK/c-jun pathway.
Liu WH; Chang LS
J Cell Physiol; 2010 Sep; 224(3):775-85. PubMed ID: 20432471
[TBL] [Abstract][Full Text] [Related]
19. Pro-inflammatory cytokines stimulate mitogen-activated protein kinase subfamilies, increase phosphorylation of c-Jun and ATF2 and upregulate c-Jun protein in neonatal rat ventricular myocytes.
Clerk A; Harrison JG; Long CS; Sugden PH
J Mol Cell Cardiol; 1999 Dec; 31(12):2087-99. PubMed ID: 10640438
[TBL] [Abstract][Full Text] [Related]
20. Matrix metalloproteinase-13 expression in IL-1β-treated chondrocytes by activation of the p38 MAPK/c-Fos/AP-1 and JAK/STAT pathways.
Lim H; Kim HP
Arch Pharm Res; 2011 Jan; 34(1):109-17. PubMed ID: 21468922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]